Balchem Corporation has announced the acquisition of Chemogas, a leading provider of specialized chemical gases for medical sterilization, significantly enhancing its market presence in Europe and Asia.

Target Company Overview

Chemogas NV, founded in 1975 and headquartered in Grimbergen, Belgium, is a leading international provider of specialized chemical gases and related services, particularly known for its extensive offering of ethylene oxide used for medical sterilization. The company specializes in filling and distributing a diverse range of chemical gases, serving clients in over 70 countries across Europe and Asia. Since its spin-off from the Linde Group in 2016, where it was part of for more than 26 years, Chemogas has experienced significant growth, including the strategic acquisition of the Malaysian Stereo Group in 2018, facilitating entry into the rapidly expanding Asian market.

Industry Overview

The global market for ethylene oxide, primarily used in the medical sterilization industry, is witnessing robust demand due to the increasing emphasis on hygiene and safety in healthcare. Ethylene oxide's efficacy as a sterilant has made it a preferred choice for sterilizing heat-sensitive medical devices, driving its consumption across hospitals and healthcare facilities worldwide.

In Belgium and broader Europe, there is a growing recognition of the importance of proper sterilization procedures, further influenced by safety regulations and standards set forth by